Prevalence and correlates of anal intercourse among female sex workers in eSwatini.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Introduction: As HIV is very effectively acquired during condomless receptive anal intercourse (AI) with serodiscordant and viremic partners, the practice could contribute to the high prevalence among female sex workers (FSW) in eSwatini (formerly known as Swaziland). We aim to estimate the proportion reporting AI (AI prevalence) among Swazi FSW and to identify the correlates of AI practice in order to better inform HIV prevention interventions among this population.
      Methods: Using respondent-driven sampling (RDS), 325 Swazi FSW were recruited in 2011. We estimated the prevalence of AI and AI with inconsistent condom use in the past month with any partner type, and inconsistent condom use during AI and vaginal intercourse (VI) by partner type. Univariate and multivariable logistic regression models were used to identify behavioural and structural correlates associated with AI and AI with inconsistent condom use.
      Results: RDS-adjusted prevalence of AI and AI with inconsistent condom use was high, at 44%[95% confidence interval (95%CI):35-53%]) and 34%[95%CI:26-42%], respectively and did not vary by partner type. HIV prevalence was high in this sample of FSW (70%), but knowledge that AI increases HIV acquisition risk low, with only 10% identifying AI as the riskiest sex act. Those who reported AI were more likely to be better educated (adjusted odds ratio(aOR) = 1.92[95%CI:1.03-3.57]), to have grown up in rural areas (aOR = 1.90[95%CI:1.09-3.32]), have fewer new clients in the past month (aOR = 0.33[95%CI:0.16-0.68]), and for last sex with clients to be condomless (aOR = 2.09[95%CI:1.07-4.08]). Although FSW reporting AI in past month were more likely to have been raped (aOR = 1.95[95%CI:1.05-3.65]) and harassed because of being a sex worker (aOR = 2.09[95%CI:1.16-3.74]), they were also less likely to have ever been blackmailed (aOR = 0.50[95%CI:0.25-0.98]) or been afraid to walk in public places (aOR = 0.46[95%CI:0.25-0.87]). Correlates of AI with inconsistent condom use were similar to those of AI.
      Conclusions: AI is commonly practised and condom use is inconsistent among Swazi FSW. Sex act data are needed to determine how frequently AI is practiced. Interventions to address barriers to condom use are needed, as are biomedical interventions that reduce acquisition risk during AI.
      Competing Interests: The authors have declared that no competing interests exist.
    • Comments:
      Erratum in: PLoS One. 2020 Apr 14;15(4):e0231487. (PMID: 32287323)
    • References:
      AIDS Res Hum Retroviruses. 2011 Oct;27(10):1067-72. (PMID: 21406032)
      Int J STD AIDS. 2003 Dec;14(12):856. (PMID: 14678597)
      Sci Transl Med. 2011 Dec 7;3(112):112re4. (PMID: 22158861)
      Am J Reprod Immunol. 2013 Feb;69 Suppl 1:95-105. (PMID: 23279040)
      J Int AIDS Soc. 2017 Jan 11;19(1):21162. (PMID: 28364565)
      Int J Gynaecol Obstet. 2013 Jan;120(1):27-31. (PMID: 23083495)
      Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9. (PMID: 21499542)
      Lancet Infect Dis. 2012 Jul;12(7):538-49. (PMID: 22424777)
      J Clin Epidemiol. 2006 Oct;59(10):1092-101. (PMID: 16980150)
      Am J Epidemiol. 2018 Feb 1;187(2):287-297. (PMID: 28633387)
      Sex Transm Infect. 2010 Jun;86(3):236-40. (PMID: 20444745)
      Am J Public Health. 1998 Aug;88(8):1265-6. (PMID: 9702169)
      J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):333-9. (PMID: 15980695)
      Sex Transm Dis. 1999 Aug;26(7):374-80. (PMID: 10458629)
      N Engl J Med. 2015 Feb 5;372(6):509-18. (PMID: 25651245)
      PLoS One. 2014 Dec 22;9(12):e115465. (PMID: 25531771)
      J Acquir Immune Defic Syndr. 2009 May 1;51 Suppl 1:S52-9. (PMID: 19384103)
      N Engl J Med. 2010 Dec 30;363(27):2587-99. (PMID: 21091279)
      Sex Transm Infect. 2013 Nov;89(7):595-601. (PMID: 23723251)
      PLoS One. 2014 Feb 20;9(2):e88858. (PMID: 24586416)
      Sex Health. 2012 Nov;9(5):430-7. (PMID: 23017434)
      Arch Sex Behav. 2000 Aug;29(4):357-73. (PMID: 10948725)
      Int J Epidemiol. 2010 Dec;39(6):1541-55. (PMID: 20630991)
      SAHARA J. 2010 Oct;7(3):44-50. (PMID: 21409304)
      Health Educ Res. 2010 Feb;25(1):14-26. (PMID: 19762354)
      Indian J Sex Transm Dis AIDS. 2012 Jan;33(1):9-15. (PMID: 22529447)
      AIDS Behav. 2015 Jul;19(7):1338-60. (PMID: 25618257)
      J Sex Res. 2014;51(8):863-73. (PMID: 24611445)
      AIDS Care. 2007 Nov;19(10):1189-93. (PMID: 18071961)
      Expert Opin Drug Deliv. 2014 Jan;11(1):69-82. (PMID: 24266648)
      Gastroenterol Clin North Am. 2013 Dec;42(4):877-92. (PMID: 24280405)
      Cult Health Sex. 2004 Jul;6(4):283-99. (PMID: 21972903)
      J Interpers Violence. 2018 Sep;33(17):2745-2766. (PMID: 26872508)
      PLoS One. 2013;8(1):e55013. (PMID: 23383037)
      AIDS Behav. 2007 Mar;11(2):325-34. (PMID: 16823626)
      Int J Epidemiol. 2010 Aug;39(4):1048-63. (PMID: 20406794)
      AIDS Res Hum Retroviruses. 2013 Nov;29(11):1443-50. (PMID: 23600365)
      AIDS Behav. 2014 Mar;18(3):573-82. (PMID: 24264727)
      Am J Epidemiol. 2003 Feb 15;157(4):364-75. (PMID: 12578807)
      Lancet. 2015 Jan 3;385(9962):55-71. (PMID: 25059947)
      Sex Transm Infect. 2006 Oct;82(5):392-6. (PMID: 16790563)
      Sex Transm Dis. 2010 Jun;37(6):361-4. (PMID: 20514687)
      Lancet. 2002 Sep 28;360(9338):971-7. (PMID: 12383665)
      BMC Public Health. 2014 Jan 25;14:79. (PMID: 24460989)
      J Int AIDS Soc. 2013 Jul 09;16:18531. (PMID: 23841994)
      PLoS Med. 2017 Nov 21;14(11):e1002444. (PMID: 29161256)
    • Grant Information:
      MR/R015600/1 United Kingdom MRC_ Medical Research Council; P30 AI094189 United States AI NIAID NIH HHS; United States PEPFAR PEPFAR
    • Publication Date:
      Date Created: 20200212 Date Completed: 20200507 Latest Revision: 20210110
    • Publication Date:
      20240105
    • Accession Number:
      PMC7012411
    • Accession Number:
      10.1371/journal.pone.0228849
    • Accession Number:
      32045444